Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
…, M van Wely, E van Leeuwen, E Kostova… - bmj, 2020 - bmj.com
Objective To determine the clinical manifestations, risk factors, and maternal and perinatal
outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus …
outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus …
SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis
…, M Van Wely, E Van Leeuwen, E Kostova… - Bmj, 2022 - bmj.com
Objectives To assess the rates of SARS-CoV-2 positivity in babies born to mothers with
SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and …
SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and …
[HTML][HTML] Positive energy districts: Mainstreaming energy transition in urban areas
The concept of Positive Energy Districts (PEDs) has emerged to facilitate the energy transition
and contribute to climate neutrality through energy efficiency and net zero energy balance. …
and contribute to climate neutrality through energy efficiency and net zero energy balance. …
[PDF][PDF] Weisfeiler-lehman graph kernels.
N Shervashidze, P Schweitzer, EJ Van Leeuwen… - Journal of Machine …, 2011 - jmlr.org
… We define a graph G as a triplet (V,E,ℓ), where V is the set of vertices, E is the set of undirected
edges, and ℓ :V → Σ is a function that assigns labels from an alphabet Σ to nodes in the …
edges, and ℓ :V → Σ is a function that assigns labels from an alphabet Σ to nodes in the …
Identification of seven loci affecting mean telomere length and their association with disease
…, J Kettunen, N Klopp, V Lagou, EM Van Leeuwen… - Nature …, 2013 - nature.com
Interindividual variation in mean leukocyte telomere length (LTL) is associated with cancer
and several age-associated diseases. We report here a genome-wide meta-analysis of …
and several age-associated diseases. We report here a genome-wide meta-analysis of …
[HTML][HTML] The UK10K project identifies rare variants in health and disease
…, A Tybjaerg-Hansen, CM van Duijn, EM van Leeuwen… - Nature, 2015 - nature.com
The contribution of rare and low-frequency variants to human traits is largely unexplored.
Here we describe insights from sequencing whole genomes (low read depth, 7×) or exomes (…
Here we describe insights from sequencing whole genomes (low read depth, 7×) or exomes (…
Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia
…, TM Bartz, X Deng, EM van Leeuwen… - Journal of the American …, 2016 - jacc.org
… van Leeuwen … The Munich Study is supported by the German Federal Ministry of Education
and Research (BMBF) in the context of the e:Med program (e:AtheroSysMed) and the FP7 …
and Research (BMBF) in the context of the e:Med program (e:AtheroSysMed) and the FP7 …
An expanded genome-wide association study of type 2 diabetes in Europeans
…, N Robertson, LC Karssen, EM Van Leeuwen… - Diabetes, 2017 - Am Diabetes Assoc
To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum,
we conducted a meta-analysis of genome-wide association data from 26,676 T2D case …
we conducted a meta-analysis of genome-wide association data from 26,676 T2D case …
[HTML][HTML] Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA
…, EM Van Leeuwen, T Lehtimäki, E Mihailov… - Nature …, 2016 - nature.com
… Finally, we perform reverse genetics using electronic health records together with the genetic
risk score to test if LPA targeting treatment for reducing CHD risk would be associated with …
risk score to test if LPA targeting treatment for reducing CHD risk would be associated with …
Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous …
…, P Kramer, JW Hoogerbrugge, EC Van Leeuwen… - …, 1995 - academic.oup.com
During fetal development, anti-müllerian hormone (AMH) is produced only by Sertoli cells,
but postnatally, granulosa cells also produce this peptide growth/differentiation factor. We …
but postnatally, granulosa cells also produce this peptide growth/differentiation factor. We …